Dongguan, China

Yingjun Zhang

USPTO Granted Patents = 62 

 

 

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 164(Granted Patents)

Forward Citations (Not Self Cited) = 149(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Guangdong, CN (2021)
  • Dongguan, CN (2015 - 2022)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
62 patents (USPTO):

Title: Yingjun Zhang: Innovating Medicine for Hepatitis B Treatment

Introduction:

Yingjun Zhang, hailing from Dongguan, China, is a prolific inventor in the field of medicine. With an impressive background in pharmaceutical research, Zhang has made significant contributions to the development of new compounds and pharmaceutical formulations. He has garnered a remarkable 57 patents, showcasing his dedication to innovation and commitment to improving healthcare.

Latest Patents:

Among Yingjun Zhang's latest patents, two stand out for their potential impact on the treatment and prevention of hepatitis B. The first patent focuses on fused tetracyclic compounds, which have shown promise as a medicament for combating hepatitis B. Zhang's invention offers a formula and various derivatives, opening avenues for further research in this crucial area.

In his second patent, Zhang explores the application of an amine compound as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor. This innovation has the potential to be used in medicines targeting a range of conditions, including inflammation-related diseases, diabetes, psychiatric disorders, ischemic diseases, vascular diseases, fibrosis, and tissue transplant rejection.

Career Highlights:

Yingjun Zhang's expertise and inventiveness have led him to work with renowned pharmaceutical companies in China. Notably, he has made significant contributions at Sunshine Lake Pharma Co., Ltd. and North & South Brother Pharmacy Investment Company Limited. Throughout his career, Zhang has demonstrated his ability to translate scientific knowledge into practical applications, earning him recognition within the pharmaceutical industry.

Collaborations:

Collaboration is often a crucial component of successful innovation, and Yingjun Zhang understands this. Two notable colleagues who have worked alongside Zhang are Qingyun Ren and Jiancun Zhang. Their collective expertise likely played a role in the development of Zhang's patents, offering diverse perspectives and pooling their knowledge to push the boundaries of pharmaceutical research and development.

Conclusion:

Yingjun Zhang's extensive patent portfolio and groundbreaking inventions highlight his dedication to advancing medicine, particularly in the treatment and prevention of hepatitis B. His fused tetracyclic compounds and amine compound inventions demonstrate his commitment to finding novel therapeutic solutions to address various diseases and conditions. As Zhang continues to contribute to the field of medicine, his work promises to have a lasting impact on patient care and the advancement of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…